Chemoinformaics analysis of 7-HYDROXY-4-METHYLCHROMEN-2-ONE
| Molecular Weight | 176.171 | nRot | 0 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 11 |
| Exact Molecular Weight | 176.047 | nRing | 2 |
| Solubility: LogS | -3.96 | nHRing | 1 |
| Solubility: LogP | 4.042 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 24.4403 |
| nHD | 1 | BPOL | 10.6297 |
| QED | 0.534 |
| Synth | 4.623 |
| Natural Product Likeliness | 2.71 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.425 |
| MDCK | 0.0000168 |
| BBB | 0.196 |
| PPB | 0.944916 |
| VDSS | 2.075 |
| FU | 0.0381171 |
| CYP1A2-inh | 0.153 |
| CYP1A2-sub | 0.706 |
| CYP2c19-inh | 0.265 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.133 |
| CYP2c9-sub | 0.388 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.808 |
| CYP3a4-inh | 0.065 |
| CYP3a4-sub | 0.435 |
| CL | 12.233 |
| T12 | 0.151 |
| hERG | 0.023 |
| Ames | 0.014 |
| ROA | 0.039 |
| SkinSen | 0.346 |
| Carcinogencity | 0.505 |
| EI | 0.73 |
| Respiratory | 0.381 |
| NR-Aromatase | 0.121 |
| Antiviral | No |
| Prediction | 0.781264 |